Guard Therapeutics
Guard Therapeutics is a Healthcare & Life Sciences startup based in Sweden, most recent round Series B, 1 tracked investor.
About Guard Therapeutics
Based in Sweden, Guard Therapeutics is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Guard Therapeutics is a clinical-stage biotechnology company focused on developing novel therapies for diseases with significant unmet medical needs, particularly kidney diseases. The company’s research is centered on the endogenous protein Alpha-1-Microglobulin (A1M), which possesses cell-protective and antioxidative properties.
Explore Guard Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.